A case study: consequences of ANTI-TNFα therapy and foot ulcerations.
2010

Impact of Anti-TNFα Therapy on Foot Ulcerations in a Patient with Ankylosing Spondylitis

Sample size: 1 publication Evidence: low

Author Information

Author(s): Edgson Lucy, Field Robert, Westlake Sarah

Primary Institution: Bournemouth and Poole Community Health Services, Bournemouth, UK

Hypothesis

What are the consequences of anti-TNFα therapy on foot ulcerations in patients with Ankylosing Spondylitis?

Conclusion

The case highlights the complications arising from anti-TNFα therapy in patients with foot wounds, including infection and impaired healing.

Supporting Evidence

  • The patient experienced foot ulceration and cellulitis after Infliximab administration.
  • Management included multiple antibiotics and weekly podiatric care.
  • Stopping Infliximab led to a flare of arthritis and complications in wound management.
  • Active inflammation impaired wound healing.

Takeaway

A patient with a foot ulcer got worse after stopping their medication, showing that the medicine can help but also has risks.

Methodology

Case study involving a 50-year-old male with Ankylosing Spondylitis treated with Infliximab.

Potential Biases

Patient reluctance to report foot problems due to perceived benefits of the drug.

Limitations

The study is based on a single case, limiting generalizability.

Participant Demographics

50-year-old male with Ankylosing Spondylitis.

Digital Object Identifier (DOI)

10.1186/1757-1146-3-S1-P6

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication